Jannick Prentoe

2.6k total citations · 1 hit paper
45 papers, 2.1k citations indexed

About

Jannick Prentoe is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jannick Prentoe has authored 45 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hepatology, 38 papers in Epidemiology and 28 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jannick Prentoe's work include Hepatitis C virus research (45 papers), Hepatitis B Virus Studies (38 papers) and Monoclonal and Polyclonal Antibodies Research (28 papers). Jannick Prentoe is often cited by papers focused on Hepatitis C virus research (45 papers), Hepatitis B Virus Studies (38 papers) and Monoclonal and Polyclonal Antibodies Research (28 papers). Jannick Prentoe collaborates with scholars based in Denmark, United States and Italy. Jannick Prentoe's co-authors include Jens Bukh, Judith M. Gottwein, Mansun Law, Tanja B. Jensen, Troels K. H. Scheel, Anne Mette Hoegh, Steven K. H. Foung, Rodrigo Velázquez‐Moctezuma, Erick Giang and Thomas H. R. Carlsen and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Immunity.

In The Last Decade

Jannick Prentoe

43 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus

2012 275 citations Erick Giang, Jannick Prentoe et al. profile →

Peers

Countries citing papers authored by Jannick Prentoe

Since Specialization

Citations

This map shows the geographic impact of Jannick Prentoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jannick Prentoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jannick Prentoe more than expected).

Fields of papers citing papers by Jannick Prentoe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jannick Prentoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jannick Prentoe. The network helps show where Jannick Prentoe may publish in the future.

Co-authorship network of co-authors of Jannick Prentoe

This figure shows the co-authorship network connecting the top 25 collaborators of Jannick Prentoe. A scholar is included among the top collaborators of Jannick Prentoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jannick Prentoe. Jannick Prentoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Selection and characterization of a broadly neutralizing class of HCV anti-E2 VH1-69 antibodies 2025 ·PLoS Pathogens ·(unknown), (unknown), (unknown), Blanca López‐Méndez, Brian Lohse, Zhaochun Chen, Patrizia Farci, Robert H. Purcell, Harvey J. Alter, Lea Barfod, Jens Bukh, Jannick Prentoe	0
2	Prevalence of HCV HVR1 insertions and their role in antibody evasion 2024 ·Hepatology ·(unknown), (unknown), Rodrigo Velázquez‐Moctezuma, (unknown), Ulrik Fahnøe, Sarah Mollerup, Uffe Vest Schneider, Kenn Holmbeck, Jens Bukh, Jannick Prentoe	0
3	The hepatitis C virus envelope protein complex is a dimer of heterodimers 2024 ·Nature ·(unknown), (unknown), Christina Grønberg, (unknown), Rodrigo Velázquez‐Moctezuma, (unknown), Jens Bukh, Kaituo Wang, Pontus Gourdon, Jannick Prentoe	9
4	Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers 2022 ·npj Vaccines ·Jannick Prentoe, Christoph M. Janitzek, Rodrigo Velázquez‐Moctezuma, (unknown), Thomas R. Jørgensen, Stine B. Clemmensen, Vladislav Soroka, Susan Thrane, Thor G. Theander, Morten A. Nielsen, Ali Salanti, Jens Bukh, Adam F. Sander	6
5	Novel HCV Genotype 4d Infectious Systems and Assessment of Direct-Acting Antivirals and Antibody Neutralization 2022 ·Viruses ·Long V. Pham, Rodrigo Velázquez‐Moctezuma, Ulrik Fahnøe, (unknown), (unknown), (unknown), Nina Weis, Kenn Holmbeck, Jannick Prentoe, Jens Bukh	2
6	Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in mice 2022 ·Journal of Hepatology ·(unknown), Shan Feng, Anna Offersgaard, (unknown), (unknown), (unknown), Tanja B. Jensen, Henrik Krarup, Mansun Law, Jannick Prentoe, Jan Pravsgaard Christensen, Jens Bukh, Judith M. Gottwein	16
7	Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 2021 ·Vaccines ·Rodrigo Velázquez‐Moctezuma, (unknown), Matteo Castelli, (unknown), Nicola Clementi, Massimo Clementi, Nicasio Mancini, Jannick Prentoe	12
8	Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens 2021 ·PLoS ONE ·Jannick Prentoe, Christoph M. Janitzek, Rodrigo Velázquez‐Moctezuma, Louise Goksøyr, Rebecca W. Olsen, (unknown), (unknown), Susan Thrane, (unknown), Judith M. Gottwein, Adam F. Sander, Jens Bukh	2
9	In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus 2021 ·PLoS Pathogens ·(unknown), (unknown), Fulvia Troise, Jens Bukh, Jannick Prentoe	6
10	In Vitro Neutralization Assay Using Cultured Hepatitis C Virus 2018 ·Methods in molecular biology ·Jannick Prentoe, Jens Bukh	7
11	Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry 2018 ·Frontiers in Immunology ·Jannick Prentoe, Jens Bukh	46
12	High density Huh7.5 cell hollow fiber bioreactor culture for high-yield production of hepatitis C virus and studies of antivirals 2018 ·Scientific Reports ·(unknown), Anna Offersgaard, (unknown), Jannick Prentoe, Ulrik Fahnøe, Henrik Krarup, Jens Bukh, Judith M. Gottwein	11
13	HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice 2015 ·Gut ·Jannick Prentoe, Lieven Verhoye, Rodrigo Velázquez‐Moctezuma, (unknown), Ali Farhoudi, Richard Wang, Harvey J. Alter, Philip Meuleman, Jens Bukh	38
14	Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a 2014 ·Hepatology ·Thomas H. R. Carlsen, (unknown), Jannick Prentoe, Erick Giang, Zhen–Yong Keck, Lotte S. Mikkelsen, Mansun Law, Steven K. H. Foung, Jens Bukh	70
15	Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1–6 2014 ·Virology ·(unknown), Tanja B. Jensen, Jannick Prentoe, Henrik Krarup, Alfredo Nicosia, Mansun Law, Jens Bukh, Judith M. Gottwein	20
16	Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies 2013 ·Hepatology ·(unknown), Thomas H. R. Carlsen, Jannick Prentoe, Santseharay Ramírez, Tanja B. Jensen, Xavier Forns, Harvey J. Alter, Steven K. H. Foung, Mansun Law, Judith M. Gottwein, Nina Weis, Jens Bukh	38
17	Analysis of Functional Differences between Hepatitis C Virus NS5A of Genotypes 1–7 in Infectious Cell Culture Systems 2012 ·PLoS Pathogens ·Troels K. H. Scheel, Jannick Prentoe, Thomas H. R. Carlsen, Lotte S. Mikkelsen, Judith M. Gottwein, Jens Bukh	34
18	Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a Isolate 2012 ·PLoS Pathogens ·Zhen‐Yong Keck, Jinming Xia, Yong Wang, Wenyan Wang, Thomas Krey, Jannick Prentoe, Thomas H. R. Carlsen, (unknown), Arvind H. Patel, Stanley M. Lemon, Jens Bukh, F.A. Rey, Steven K. H. Foung	182
19	Hepatitis C virus expressing flag-tagged envelope protein 2 has unaltered infectivity and density, is specifically neutralized by flag antibodies and can be purified by affinity chromatography 2010 ·Virology ·Jannick Prentoe, Jens Bukh	22
20	Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs # † 2008 ·Hepatology ·Judith M. Gottwein, Troels K. H. Scheel, Tanja B. Jensen, (unknown), Jannick Prentoe, Maria L. Knudsen, Anne Mette Hoegh, Jens Bukh	304

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact